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Abstract
Background: The Hedgehog (Hh) signaling pathway, acting through three homologous transcription factors
(GLI1, GLI2, GLI3) in vertebrates, plays multiple roles in embryonic organ development and adult tissue homeostasis.
At the level of the genome, GLI factors bind to specific motifs in enhancers, some of which are hundreds of kilobases
removed from the gene promoter. These enhancers integrate the Hh signal in a context-specific manner to control the
spatiotemporal pattern of target gene expression. Importantly, a number of genes that encode Hh pathway molecules
are themselves targets of Hh signaling, allowing pathway regulation by an intricate balance of feed-back activation and
inhibition. However, surprisingly few of the critical enhancer elements that control these pathway target genes have
been identified despite the fact that such elements are central determinants of Hh signaling activity. Recently,
ChIP studies have been carried out in multiple tissue contexts using mouse models carrying FLAG-tagged GLI
proteins (GLIFLAG). Using these datasets, we tested whether a meta-analysis of GLI binding sites, coupled with a
machine learning approach, could reveal genomic features that could be used to empirically identify Hh-regulated
enhancers linked to loci of the Hh signaling pathway.
Results: A meta-analysis of four existing GLIFLAG datasets revealed a library of GLI binding motifs that was substantially
more restricted than the potential sites predicted by previous in vitro binding studies. A machine learning method
(kmer-SVM) was then applied to these datasets and enriched k-mers were identified that, when applied to the mouse
genome, predicted as many as 37,000 potential Hh enhancers. For functional analysis, we selected nine regions which
were annotated to putative Hh pathway molecules and found that seven exhibited GLI-dependent activity, indicating
that they are directly regulated by Hh signaling (78 % success rate).
Conclusions: The results suggest that Hh enhancer regions share common sequence features. The kmer-SVM machine
learning approach identifies those features and can successfully predict functional Hh regulatory regions in genomic
DNA surrounding Hh pathway molecules and likely, other Hh targets. Additionally, the library of enriched GLI binding
motifs that we have identified may allow improved identification of functional GLI binding sites.
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Background
The Hedgehog (Hh) signaling pathway is critical for em-
bryonic organ development and adult tissue homeostasis
across animal phyla [1–4]. In multiple tissue-specific
settings, Hh signaling directs specific cell fate choices,
controls tissue patterning and governs cell proliferation.
In mammals, Hh signaling originates with any of three
ligands (Sonic hedgehog (Shh), Indian hedgehog (Ihh) or
Desert hedgehog (Dhh)) (for Review see [5]). Release of
the lipid modified HH ligand has been shown to be facili-
tated by SCUBE in conjunction with the transmembrane
protein Dispatched [6–9]. Once discharged, HH ligands
interact with the Patched (PTCH1 or PTCH2) receptor
protein and with Hh-binding proteins BOC, CDO and
GAS1 on target cells to relieve PTCH-dependent in-
hibition of the Smoothened (SMO) transmembrane
protein [10, 11]. HH ligands can also be sequestered by
the Hedgehog-interacting protein (HHIP), which dampens
signaling [12].
Hh-mediated signal transduction culminates in the
nucleus, with the binding of zinc-finger transcription
factors (GLI1, GLI2, GLI3) to target gene sequences
[13, 14]. However, proteolytic processing determines
whether the GLI proteins act as repressors or activa-
tors. GLI1, which is not processed, functions exclusively
as a transcriptional activator and may act to amplify Hh
signals [15]. GLI2 and GLI3 can be converted to a re-
pressor form in the absence of Hh ligand. In the pres-
ence of the Hh ligand, this processing is inhibited,
allowing full-length GLI proteins to traffic to the nu-
cleus and activate gene expression [15–17]. Processing
of GLI proteins requires passage through the cilia [13, 18];
the kinesin KIF7 helps to properly construct the cilium
and is enriched at the cilium tip, along with GLI and
SUFU (Suppressor of Fused) [19].
The Hh signaling pathway is regulated by both positive
and negative feedback. Indeed, a number of Hh pathway
components, including Boc, Cdo, Gas1, Gli1, Hhip, Ptch1
and Ptch2 are thought to be direct transcriptional targets
of Hh signaling in multiple tissue contexts [12, 15, 20–29].
Thus, an important aspect of Hh pathway self-regulation
is integrated at the level of the enhancers that control
response of the pathway target genes to local Hh signaling
levels. However, despite the high functional conservation
of this pathway, surprisingly little is known about the
enhancer elements that control self-regulation in any
organism.
One way to identify Hh target enhancers is to perform
chromatin immunoprecipitation (ChIP). Genetically modi-
fied mouse models carrying inducible FLAG-tagged GLI
proteins have allowed analysis of GLI binding sites in vivo
in several different tissue contexts. Four in vivo GLI bind-
ing studies, including three ChIP-chip analyses [26, 27, 29]
and one ChIP-seq study [25], have been carried out using
these models. Interestingly, examination of all four data-
sets for common GLI binding sites that are annotated to
Hh pathway molecules reveals only three such sites (in
Gli1, Ptch1, and Ptch2 loci [15, 24, 28]) that are uniformly
detectable. Several other established Hh pathway genes,
including Boc, Hhip, Gli2, and Hipk2, appear to exhibit
different GLI-bound genomic locations, depending on
context, suggesting that each of these pathway compo-
nents is regulated by multiple distinct genomic enhancers
that have context-specific features.
Using ChIP studies on diverse tissues, it may be pos-
sible to eventually identify all of the multiple enhancers
that control each target gene in every context. While a
valuable goal, such analyses are currently expensive and
time consuming and often technically challenging where
the number of cells available for analysis is limiting, as in
many developmental contexts. Importantly, computational
methods can reveal sequence features that characterize
enhancer activity. We therefore asked whether analysis of
all existing GLI ChIP data could reveal common sequence
features that might be used to empirically and globally
predict functional enhancers de novo. A publicly available
machine learning approach, kmer-SVM [30], was used to
predict novel Hh enhancer regions. This tool uses a
support vector machine (SVM) to determine sequence
features (k-mer frequencies) that identify positive genomic
regulatory regions [31]. SVMs are classifier algorithms
that define a boundary between members of two different
groups. Kmer-SVM calculates weights for sequence fea-
tures that determine the effectiveness of that feature to
distinguish between positive and negative regulatory re-
gions. Once the features are determined, they can be used
to identify novel enhancer regions not present in the
original positive set. The strength of this approach is that
it relies exclusively on short regions of DNA sequence
(length 3–10 bp) which are in the size range of tran-
scription factor binding sites (TFBS). Additionally, the
organization of the k-mers within a sequence does not
impact the score; this feature is consistent with the
variable arrangement of TFBS in enhancers [32, 33].
Using the kmer-SVM tool [30], analysis of the four
existing GLI binding datasets identified a set of k-mers
that appeared to successfully predict potential GLI-
regulated enhancers. Application of this set of k-mers
to the mouse genome pinpointed over 37,000 potential
enhancers. Several putative enhancers that were anno-
tated to Hh pathway components were then tested for
their ability to drive Hh-dependent activity in transfected
cells. The functional significance of the GLI binding
motifs (GBM) was also tested within each active enhancer
by mutation. Of the nine predicted regulatory regions
tested, seven (78 %) drove reporter expression in a GLI-
dependent fashion. These findings substantially increase
the number of functionally verified Hh enhancers found
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in Hh pathway molecules and validate the use of machine
learning on ChIP data as a valuable tool to empirically
predict likely Hh-dependent regulatory regions.
Results and discussion
Analysis of GLIFLAG datasets to identify likely in vivo GLI
transcription factor binding motifs
A previous in vitro analysis of GLI transcription factor
binding resulted in the identification of a set of likely
binding sites for this factor [34]. However, this spectrum
of sites may not accurately represent GLI binding site
preferences in vivo. To begin to examine this, we per-
formed a meta-analysis of four existing GLI-ChIP datasets.
All of these datasets utilize transgenic mice carrying
FLAG tagged GLI1 (GLI1FLAG) or GLI3 (GLI3FLAG) in the
ROSA26 locus, activated by Cre recombination, in four
different tissue contexts: limb bud development (LD) [27],
cerebellum development (CD), medulloblastoma (MB)
resulting from Hh signaling overexpression [29], and
neural progenitor cells (NP) [25]. An additional study of
neural progenitors [26] was excluded from analysis since
it contained a low number of significant peaks and mirrors
the same experimental conditions as the NP dataset [25].
For each of the datasets, the reported percentage of ChIP
peak sequences with GLI binding motifs (GBM) was as
follows: LD 55 %, CD 26 %, MB 46 %, and NP 91 %. How-
ever, the definition of GBM was not the same across all
datasets: one study allowed only two mismatches from the
consensus [27] and others generated a GLI motif de novo
based on the sequences of recovered peaks [25, 29].
To collate the spectrum of GBM observed in all four
datasets, we applied a de novo motif enrichment analysis
to each dataset individually [35]. Sequences that contained
at least one site that matched the de novo motifs were re-
moved from the dataset. The remaining sequences were
analyzed for residual motifs that resembled a GBM using
DREME [36] and Tomtom [37] (see Methods). This re-
sulted in 548 putative GBM (12-mers) (Additional file 1:
Table S1), encompassing the range of GBM that are
present in existing ChIP data. This set therefore represents
a collection of likely genomic GLI binding sites, although
some functional GLI binding sites in vivo could be absent
from this set and some false positive sites may be in-
cluded. Each 12-mer was classified as high confidence
(HC), medium confidence (MC), or low confidence (LC) if
it was found within sequences from all four datasets, two
to three datasets, or one dataset, respectively. The sequence
logos [38] for each classification, provided in Fig. 1a, show
a nearly absolute representation of CCxC in positions 4–7
for all sites. Indeed, concordant (C and C or G and G)
Fig. 1 Definition of GLI binding motifs (GBM) and characterization of GLIFLAG datastets. a Sequence logos (Weblogo) of 12-mer GBM. High confidence
(HC), medium confidence (MC), and low confidence (LC) GBM are found in all four (HC), three or two (MC) or one (LC) datasets. b Relative frequency
of peaks containing one or more GBM in the GLIFLAG ChIP-chip LD (red), CD (blue), MB (green), and GLIFLAG ChIP-seq NP (yellow) datasets. A
high proportion of sequences contain only one GBM. c Overlap of sequences identified by all four GLIFLAG datasets; only 26 individual peaks
are found in all contexts
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nucleotides at the 5th and 7th position were previously
found to be required for GLI binding [39]. Interestingly, for
high confidence sites, there is no variation at 5 of the
12 positions, including the 5th and 7th positions
(xGxCCxCxCxxx).
Using the recommended matrix similarity score cutoff
of 81 % overall matrix similarity to the optimal consen-
sus GLI site as defined by the in vitro DNA binding
assay [34] results in 1,432,161 putative GLI TFBS across
the mouse genome. This is substantially more than the
191,745 found using the new GLI library defined by the
in vivo ChIP studies. However, several of the sites pre-
dicted by the in vitro binding studies do not contain the
concordant (C and C or G and G) nucleotides at the 5th
and 7th position. Thus, the newly generated GLI library
(Fig. 1a) may more accurately represent functional GBM.
According to this new library of 548 GBM, 41 % of
LD, 27 % of CD, 32 % of MB, and 80 % of NP peaks con-
tain putative GLI binding sites. For those sequences that
contain a GBM, the vast majority contain only a single
site (85.5 % LD, 90.7 % CD, 88.0 % MB, 89.8 % NP)
(Fig. 1b). The overlap of genomic binding regions among
datasets is shown in Fig. 1c; only 26 genomic coordi-
nates are shared among all datasets (Additional file 2:
Table S2). Since pathway components must respond to
the Hh signal in all tissues, it might be expected that this
common response would be integrated by a single en-
hancer. However, only three of the 26 shared regions
are annotated to known Hh pathway components
(Gli1, Ptch1, Ptch2). Indeed, for Boc and Hhip, distinct
genomic GLI binding regions are found in different
datasets. This result suggests that some of these genes
may have multiple enhancers that work to transduce
the Hh signal in different tissue contexts.
Given this apparent complexity in regulatory regions,
we next asked whether the existing datasets of ChIP peaks
might contain additional sequence information that could
be used to predict the location of other Hh-responsive
enhancers in the mouse genome. A machine learning
approach was employed to test this question.
Assessment of kmer-SVM performance and prediction
Kmer-SVM assessment of classification using GLIFLAG
datasets
For each GLIFLAG dataset, only sequences with at least
one GBM (wGBM, meaning with GBM) were used. This
was done since a high proportion of the ChIP-chip data-
sets did not contain a putative GLI binding site as de-
fined in the original papers (LD 55 %, CD 26 %, MB
46 %, and NP 91 %) or by our assessment (41 % of LD,
27 % of CD, 32 % of MB, and 80 % of NP peaks). Each
individual dataset was submitted to kmer-SVM and the
ability of each classifier to correctly label a candidate se-
quence as positive was assessed. Background sequences
were randomly selected from the genome, but matched
for GC content with the positive set.
Kmer-SVM randomly divides the data as follows: 80 %
of the sequences are used as a training set and 20 % are
used as a testing set. The ability of the classifier built
with the training set to accurately identify the members
of the remaining 20 % testing set is then assessed. This
is repeated five times, each with a different random
division of the data. Receiver operating characteristic
(ROC) curves and precision recall curves (PRC) are used
to assess the success of the classifier to correctly label
regions in the testing set as positive (see Methods).
ROC curves display the cumulative distribution of the
true positive rate compared to the false positive rate.
This characteristic assesses how well the classifier is able
to label the positive sequences from the test set. The
area under the curve was 0.898 for LDwGBM (Fig. 2a),
0.856 for CDwGBM (Fig. 2b), 0.862 for MBwGBM
(Fig. 2c) and 0.976 for NPwGBM (Fig. 2d). Thus, the
classifier performs best in LD and NP datasets.
PRC displays the predictive value against the true posi-
tive rate and represents the accuracy of the labeling. The
PRC plots indicated high values for LDwGBM (AUC =
0.753) and NPwGBM (AUC = 0.880) but low values for
CDwGBM (AUC = 0.490) (Fig. 2f ) and MBwGBM
(AUC = 0.546) (Fig. 2e-h). The ROC and PRC plots for
LDwGBM and NPwGBM datasets suggested that the
classifier sequence features used were able to distin-
guish between positive and negative groups with a low
level of false labeling.
Predictions
The classifiers for LDwGBM and NPwGBM were then
individually run on 600 bp of sequence centered on
every GBM in the mouse genome (191,745, as deter-
mined using the new GBM from in vivo data, described
above). Use of both the LDwGBM and NPwGBM data-
sets for prediction incorporated data from the GLI1FLAG
(predominately activator) and GLI3FLAG (predominantly
repressor) transcription factors in two diverse contexts
(neuronal precursor and limb development).
The length of 600 bp was selected based on motif
enrichment analysis of the LD and NP datasets using
MEME-ChIP [40] and Centrimo [41]. This analysis
showed that, within the ChIP-chip LD dataset, enrich-
ment for the location of GLI motifs (green line) has a
broad profile that spans 200 bp to either side of the
midpoint (Additional file 3: Figure S1A). The GLI motif
has a narrower profile in the NP data, a feature that is
expected for ChIP-seq (Additional file 3: Figure S1B).
The profile for the Sox motif (blue line), an established
tissue specific GLI cofactor [25], shows an enrichment
peak that is centered around 200 bp on either side of the
midpoint (Additional file 3: Figure S1B) and suggests
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that cofactors for Hh may reside outside of the immediate
vicinity of a GLI binding site. We therefore used 600 bp to
capture both common Hh features as well as potential
context specific sequence.
For the LDwGBM classifier, scores ranged from −4.33
to 12.00 with 18.4 % of the 191,745 analyzed genomic
regions scoring as positive (Score > 0). The NPwGBM
results ranged from −2.54 to 5.48 with 5.7 % positive
(Fig. 3a; Additional file 4: Table S3). The categorization
of a sequence is dependent on the sign of the score and
the weight of the value is less important than the rank-
ing. Overall, the correlation between scores for individ-
ual genomic regions calculated by the LDwGBM and
NPwGBM classifiers is poor (0.68 Pearson) (Fig. 3b).
However, if only sequences with positive scores are
considered, the correlation improves (0.85 Pearson). If
scores are restricted to values indicating only the high
confidence scores (calculated posterior probabilities = 1.0,
Additional file 5: Figure S2), the values are very well corre-
lated (0.96 Pearson). In total, 8627 genomic regions were
predicted as Hh enhancers by both classifiers. Of those,
1198 regions (14 %) overlapped at least one peak in the
four GLIFLAG datasets. Among high confidence scores
(LDwGBM: 5951 ≥ 1, NPwGM: 547 ≥ 1) 528 genomic
regions were shared between the two datasets and 187 of
these (35 %) overlapped with peaks from at least one of
the four GLIFLAG datasets. All of the scored regions are
listed in Additional file 4: Table S3.
Evaluation of predictions
To assess whether kmer-SVM predictions were likely to
represent Hh enhancers, we examined whether the pre-
dicted genomic regions overlapped publically available open
chromatin and enhancer histone marks in tissues that were
likely to be transducing Hh signals. We first examined the
DNaseI hypersensitive profile collected from mouse
mesoderm at E11.5 at genomic regions that were pre-
dicted with high confidence as positive (1 ≤ score; pos-
terior probability = 1) or negative (−1 ≥ score; posterior
probability = 0) (Additional file 5: Figure S2). A signifi-
cantly higher proportion of overlap was found with the
predicted positive regions than with predicted negative
regions (Z-Score = 2.8332; p-value < 0.05) (Additional
file 6: Table S4). We also examined publically available
H3K4me1, H3K4me3, and H3K27ac ENCODE data col-
lected from heart and liver at E14.5. Monomethylated
H3K4 (H3K4me1) and histone H3 acetyl Lys27 H3K27ac
[42] were used as enhancer markers while trimethylated
H3K4 (H3K4me3) was expected to be depleted in enhan-
cer regions [43]. Although Hh signaling is active during
early development of both tissues, available in situ analysis
for GLI1 (GenePaint: EN1215) [44, 45] shows GLI1
expression in liver but not heart at E14.5 (Additional
file 7: Figure S3). Thus, we expected signals for both
H3K4me1 (poised enhancer) and H3K27ac (active en-
hancer) to be enriched in the predicted positive re-
gions in liver but not heart at this time point. Indeed
Fig. 2 Assessment of classification capability of kmer-SVM trained GLIFLAG datasets containing sequences with at least one GBM. For all curves,
each dataset is randomly split into 80 % for training and 20 % for prediction and the prediction is repeated five times (represented by individual
lines). Plots assess the likelihood that the specified classifier can successfully predict sequences that have at least one GBM as positive or negative.
a-d ROC plots depicting true positive rates (TPR) and false positive rates (FPR). Area under the curve (AUC) scores as calculated by kmer-SVM are:
0.89 for LDwGBM (a), 0.85 for CDwGBM (b), 0.86 for MBwGBM (c) and 0.97 for NPwGBM (d) datasets. e-h Precision recall curves depicting the
positive predictive value (PPV), calculated as true positive / (true positive + false positive), versus the TPR. AUC of 0.75 for LDwGBM (e) and 0.88
for NPwGBM (h) indicate reasonable confidence in the classification while AUC of 0.49 for CDwGBM (f) and 0.55 for MBwGBM (g) indicate a low
probability that the region is correctly labeled when the sequence is classified as positive
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this was the case: H3K4me1 (Z-Score = 2.5511; p-value <
0.01) and H3K27ac (Z-Score = 8.076; p-value <0.01), with
no significant difference in H3K4me3 when predicted
positive regions were compared to predicted negative re-
gions. As expected, the heart data did not show enrich-
ment for H3K4me1 or H3K27ac. Together, the results
(summarized in Additional file 6: Table S4) are consistent
with the conclusion that the kmer-SVM classification cor-
rectly identifies Hh enhancer regions.
Next, we evaluated the sequence features, or k-mers,
that kmer-SVM identified as primary components of Hh
enhancer regions. The weights of k-mers are calculated
during the SVM training and reflect the contribution of
the k-mer to categorization of a sequence. Weights can
be positive or negative and the sum of the weights of
iterative k-mers across a sequence comprise the overall
score of that sequence. Not surprisingly, alignment of k-
mers with high scoring weights shared between both
datasets returned a motif that strongly resembles the
GBM (Fig. 3c). Unique high weighted k-mers that oc-
curred in each individual dataset represented potential
context specific features. An E-box motif was identified
for the LDwGBM dataset while a Sox motif was returned
for NPwGBM (Fig. 3d). Negative weights that occurred
in both datasets include AC and ACC repeats as well as
other C rich sequences.
Functional verification of GLI-dependent enhancer activity
Predicted genomic regions were annotated to the two
nearest genes using GREAT [46]. Because our goal was
to identify enhancers for Hh pathway components, we
selected a subset of predictions that were positive in
both the LDwGBM and NPwGBM datasets and that were
annotated to members of the GO:0007224 Smoothened
signaling pathway gene set. Because Hh pathway compo-
nents are required for active Hh signaling, we reasoned
that enhancers annotated to these genes would be more
likely to function in any tissue that transduces Hh signal.
Therefore, high scoring regions annotated to different
members of the GO:0007224 gene set that were readily
cloned were functionally tested for enhancer activity. Two
previously known Hh enhancers for Ptch1 and Ptch2
appeared on this list [24, 28]. Interestingly, an estab-
lished Gli1 regulatory region was not predicted [15].
The test set consisted of genomic regions annotated to
Boc, Gli3, Hhip, Hipk2, Ptch1, Scube1, Shh, and Tgfbr2.
An additional region, annotated to Dpp6 (near Shh)
was also tested (Table 1).
The nine genomic regions were screened for Hh respon-
siveness in a cell culture assay that has been previously
used to validate Hh enhancers [47, 48]. In this assay,
C2C12 cells are transiently transfected with constructs
containing the putative Hh regulatory region cloned
Fig. 3 Assessment of genomic kmer-SVM predictions using classifiers trained on LDwGBM and NPwGBM datasets. a All genomic sequences matching
the restricted 548 GBM 12-mers (wGMB) were identified and the 600 bp surrounding each GBM were assessed and scored using the kmer-SVM classifier
that was trained on each of the two datasets. b Correlation plot depicting the relationship between LDwGBM and NPwGBM scores; scores >1 are highly
correlated in the two datasets. c GLI motif generated from overlapping high weighted k-mers shared between LDwGBM and NPwGBM
classifiers. d High weighted k-mers (identified by Tomtom) represented in either LDwGBM (Tcf and Zfp) or NPwGBM (Fox and Sox)
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upstream of a minimal promoter that drives luciferase
expression (see Methods). To induce a Hh response,
enhancer reporter constructs were co-transfected with
a plasmid that drives constitutive expression of GLI1 in
mammalian cells [26]. For those candidate enhancers that
demonstrated apparent Hh activation, GLI-dependent ac-
tivity was confirmed by retesting after mutagenesis of the
GLI binding sites (GKO). Either complete loss of enhancer
activity or attenuation of response in GKO sequence was
considered GLI-dependent. The established Hh enhancer
region for Ptch2 was used as a positive control [28].
For the 9 regulatory regions annotated to Hh pathway
component genes, 7 exhibited Hh activation that was dir-
ectly dependent on a GLI binding site (Fig. 4). The Ptch2
positive control region showed a complete loss of Hh re-
sponse after mutation of the GLI site (Fig. 4) as did the
regulatory regions annotated to Hhip, Hipk2, Ptch1, and
Scube1. Regions annotated to Boc, Dpp6, and Tgfbr2
showed a significant decrease in Hh activation upon GLI
TFBS mutation, but not a complete loss of response. This
suggests that additional regulatory inputs influence the ac-
tivity of these enhancers. Neither the Gli3 nor Shh region
exhibited Hh dependent enhancer activity. However, we
cannot rule out the possibility that these regions might be
positive if examined in a different cellular context [26].
Two previous in silico methods have been described
for the identification of Hh-regulated enhancers in verte-
brates: Enhancer Element Locator (EEL) and Module
Cluster Analysis (MCA). EEL analyzes the estimated en-
ergy of a single transcription factor binding event, as
well as the possible interaction between adjacent, highly
conserved transcription factor binding sites, to detect
potential enhancers [34]. In contrast, MCA utilizes Pois-
son modeling to determine the relative enrichment of
binding sites in highly conserved, non-coding sequence
and, thereby, identify putative enhancers [26]. While
both of these methods have had some success (~25 %)
in detecting putative Hh-regulated enhancers, a disad-
vantage to these approaches is that the search is limited
to regions of high sequence conservation and to regions
close to promoters. In contrast, kmer-SVM approach
used here employs a genome-wide empirical analysis to
locate regions that contain sequence features predictive
of Hh enhancer function. Though these predictions miss
one of the three known Hh pathway enhancers [15] indi-
cating that the algorithm does not capture all Hh-driven
enhancers, the high success rate (78 %) of the kmer-
SVM predictions far exceed the previous prediction rates
for EEL or MCA. It is important to note, however, that
the predictions tested here are all for pathway genes,
which may have a unique signature. It would be necessary
to test additional enhancers in tissue-specific assay
Table 1 Assessment of predicted Hh enhancer regions
Annotated gene Genomic coordinates (mm9) Hh responsive LD CD MB NP
Ptch2 chr4:116,767,757-116,769,455 + + + + +
Boc chr16:44,502,136-44,503,346 + - + + -
Dpp6 chr5:27,248,056-27,249,266 + + - - -
Gli3 chr13:15,764,694-15,765,904 - - - - -
Hhip chr8:82,838,195-82,839,405 + + - - +
Hipk2 chr6:38,614,001-38,615,211 + - - - -
Ptch1 chr13:63669992-63671202 + + - + +
Scube1 chr15:83503053-83504263 + - - - -
Shh chr5:28832033-28833243 - - - - -
Tgfbr2 chr9:116,151,184-116,152,394 + - - - -
Seven of the nine regions predicted to be GLI-driven enhancers were indeed determined to be Hh responsive and GLI binding site dependent in a cell culture
assay. Overlap of the predicted regions with peaks from the GLIFLAG ChIP datasets (LD, CD, MB, NP) is indicated by the plus sign. Boc, Hipk2, Scube1 and Tgfbr2
were predicted by kmer-SVM and found to be positive, even though those regions do not overlap any of the peaks identified in the LD or NP datasets used to
generate the kmer-SVM classifier
Fig. 4 Functional verification of GLI-dependent enhancer activity.
Putative regulatory regions were cloned upstream of a minimal
promoter co-transfected into C2C12 cells, along with a GLI1 expression
vector. Relative activity is plotted (stimulated/basal). The Ptch2 region is
used as a positive control. Novel regions annotated to the Boc, Dpp6,
Hhip, Hipk2, Ptch1, Scube1, and Tgfbr2 loci exhibit upregulation in
response to GLI1 co-transfection (green). Dependence on GLI was
assessed by mutating all putative GLI TFBS (GKO) within the sequence
and retesting in the assay (gray)
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systems (e.g., transgenic mice) to determine the overall
success of this method in identification of tissue-specific
enhancers.
To examine the impact of k-mers that contribute to
predictions of the positive regions, weights were plotted
across each of the sequences. The Ptch2 sequence (Fig. 5a),
a known enhancer region [28], contained matching pro-
files for 8-mers predicted from LDwGBM (red) and
NPwGBM (yellow) that are GC rich and similar to the
GBM k-mers However, mutation of the single GLI TFBS
(Fig. 5b, green box) ablates the Hh response, indicat-
ing that the presence of this GBM is required to trans-
duce Hh signaling. Mutation of the GBMs annotated
by the green boxes for Hhip, Hipk2, Ptch1, and Scube1
(Fig. 5e, f, g, h) is also sufficient to abrogate Hh signal
transduction. For Boc, Dpp6, and Tgfbr2, which show
enhancer activity that remains after ablation of the
GBM (Fig. 5b, c, j), there were no sequence character-
istics that were indicative of a shared feature respon-
sible for this remaining response to induction by GLI1.
The Boc profile was the only one that contained a high
weighted k-mer (annotated with an asterisk) that was
unique to the LDwGBM (red) profile. This k-mer was
similar to a Krox motif (Tomtom p-value < 0.004) [37]
and may be enriched in the LDwGBM dataset as a con-
text specific transcription factor, since it has roles in
limb development [49, 50]. In general, most of the
tested regions contain distributed high weighted 8-mers in
Fig. 5 K-mer weights plotted across sequences that show enhancer activity. Diagrams were generated in UCSC Genome browser and
show coordinate information for regions annotated to Ptch2 (a), Boc (b), Dpp6 (c), Gli3 (d), Hhip (e), Hipk2 (f), Ptch1 (g), Scube1 (h), Shh (i)
and Tgfbr2 (j). Green boxes represent GBM. Weights for LDwGBM and NPwGBM are represented by the red and yellow lines, respectively.
Refseq gene annotations are represented in blue. A putative Krox-20 TFBS (*) that has a high weight in the LDwGBM classifier but not
the NPwGBM classifier occurs in the sequence annotated to Boc. Note that most sequences show weighted k-mers located several
hundred bp from the central GBM, suggesting that sequence motifs that predict Hh enhancer activity may be distributed
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addition to the central GBM and had profiles that con-
tained consistent peaks in both LDwGM and NPwGBM
datasets (Fig. 5).
Conclusions
We have utilized the kmer-SVM machine learning ap-
proach to examine four existing GLI ChIP databases and
to generate classifiers that can empirically predict func-
tional Hh enhancers from genomic DNA. The analysis
was facilitated by a new GBS library generated from a
meta-analysis of genomic regions identified in in vivo
binding studies [25–27, 29]. When compared to the pre-
vious library derived from in vitro binding studies [34],
this new GBS library resulted in the identification of a
subset (approximately 10 %) of potential GLI transcrip-
tion factor binding sites across the mouse genome. Of
nine predicted Hh target regulatory regions tested, seven
were functionally verified as GLI-dependent. All of the
tested regions were annotated to genes believed to be
components of the Hh pathway and important determi-
nants of the Hh response. Given the high success rate of
Hh enhancer prediction in this small scale screen (78 %),
it is quite possible that a large number of the other
37,000 predicted regions (Score > 0 in Additional file 4:
Table S3) may harbor Hh enhancer activity.
Methods
Computing resources
Except where otherwise indicated, all computational steps
were performed using custom Perl and R scripts.
Publically available datasets
Genomic analysis was conducted on chromosomes 1 to
19, X and Y of mouse build mm9. Mouse ENCODE data
[51] comprising open chromatin DNaseI data that was
collected at embryonic day 11.5 in the mesoderm and
histone (H3K4me1, H3K4me3, and H3K27ac) data
collected from embryonic day 14.5 for heart and liver
were downloaded from the UCSC genome repository
(goldenPath).
Definition of putative GLI binding motifs
The library of putative GLI binding motifs (GBM) was
compiled using de novo motif analysis [35] on each of
the individual GLIFLAG datasets iteratively. Sequences
that contained a GBM were removed from the dataset
and the remaining sequences were analyzed for enriched
motifs using DREME [36]. If Tomtom [37] returned a
GLI motif, the dataset was reanalyzed using
HOMER [35]. The process continued until no residual
GBM remained enriched in the dataset. Confidence in
the GBM was classified as high (HC) if it was shared
across sequences from all four GLIFLAG datasets,
medium (MC) if it was found in two or three datasets,
and low (LC) if it only occurred in one.
kmer-SVM parameters and evaluation of classifiers
Training was run on the Beer lab webserver (http://
kmersvm.beerlab.org/), using a k-mer of length of 8.
Performance of the classifier built by kmer-SVM’s
training algorithm was assessed using Receiver Operating
Characteristic (ROC) and Precision-Recall curves (PRC)
generated within the kmer-SVM program. True positive,
true negative, false positive and false negative counts were
generated by segregating the sets of positive and negative
sequences into a training set (80 % of the sequences) and
a testing set (the remaining 20 % of the sequences). Each
member (individual sequence) of the testing set that is
correctly annotated as positive increases the true positive
count while an incorrect prediction of a positive sequence
as negative increases the false negative count. ROC curves
asses the sensitivity and specificity of the classifier output.
A steep curve with a high area under the curve (AUC) in-
dicates a high true positive rate and a low false positive
rate. PRC evaluate the accuracy and relevance of the clas-
sifier output. A high AUC indicates that the results have a
low false positive rate (high precision) and a low false
negative rate. The trained SVM is evaluated by assessing
its ability to classify the testing set correctly. The classifier
was assessed five times by resetting members in the
training set and testing set.
Cloning of putative enhancer regions
Putative enhancers were amplified from C57BL/6
genomic DNA (supplied by Jackson Laboratory) using
template-specific PCR primers (Additional file 8: Table S4).
A CACC extension was added to the end of one primer to
facilitate directional cloning. PCR fragments were cloned
into the pENTR/D-TOPO vector using the standard kit
(Invitrogen) and then shuttled into the pGL3-Promoter lu-
ciferase vector (Promega) using the Gateway® cloning sys-
tem (Invitrogen). QuikChange mutagenesis (Stratagene)
was used to mutate putative GLI binding sites by replacing
the C in the 6th position to a G.
Luciferase assay
C2C12 cells (35,000) were plated per well on 12-well
plates (10 % fetal bovine serum treated with penicillin,
streptomycin and glutamate). After 24 h, cells were
transfected, using lipofectamine, with 400 ng of the
construct containing the putative enhancer region plus
either a control vector or GLI1 (in equal molecular
weight). Renilla (Promega pRL-CMV) was also included
to normalize transfection efficiency. After an additional
24 h, cell media was changed to no serum to promote
ciliogenesis [52]. Cell lysate was collected after 48 h and
measured for luciferase activity using the Dual-Luciferase®
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Reporter Assay System (Promega) on a Perkin Elmer
Wallac Victor3 1420 Multilabel Counter. Three experi-
mental replicates were collected for each condition.
Additional files
Additional file 1: Table S1. GLI binding motif 12-mers. Library of 12-mers
enriched in GLIFLAG datasets. Motifs were considered high confidence (HC) if
the 12-mer occurred in all four GLIFLAG datasets, medium confidence (MC) if it
occurred in 2 or 3, or low confidence (LC) if it only occurred in one dataset.
(XLSX 17 kb)
Additional file 2: Table S2. Peak coordinates that overlap between all
four GLIFLAG datasets. The 26 regions that have shared peaks across all
GLIFLAG datasets. Peaks are annotated to nearest genes. (XLSX 9 kb)
Additional file 3: Figure S1. Determination of sequence length buffer
surrounding the GBM. Plots depicting the positional distribution of the
best GLI motif (green) were generated by submitting 300 bp of sequence
surrounding the center of each peak to Centrimo. (A) LDwGBM shows a
broad profile for the best GBM, consistent with ChIP-chip data. (B) The
profile for the ChIP-seq sequences from NPwGBM is more narrow and
suggests that most of the GBM fall within 240 bp around the center of
the peak. In neural precursor cells, the motif for the GLI cofactor, Sox, has
a profile that contains a central apex plus two additional summits at a distance
of 240 bp on either side of the peak. This suggests that context-specific TF
binding may occur outside the central peak region. (TIF 15871 kb)
Additional file 4: Table S3. GLIFLAG dataset kmer-SVM scores. kmer-SVM
scores for LDwGBM and NPwGBM datasets. (XLSX 20714 kb)
Additional file 5: Figure S2. Posterior probability of kmer-SVM scores.
Plots depicting the posterior probabilities assigned to scores for both (A)
LDwGBM and (B) NPwGBM datasets. The graphs indicate that scores above
1 have a high confidence of being Hh regulatory regions. (TIF 14263 kb)
Additional file 6: Table S4. Overlap of predicted high confidence
positive and negative regions with embryonic open chromatin. Tabulation
of the number of genomic regions predicted by both LDwGBM and
NPwGBM that are classified with high confidence as Hh enhancer
regions or as nonregulatory regions that overlap with mesoderm
DNaseI (E 11.5) or enhancer markers (E14.5). (XLSX 9 kb)
Additional file 7: Figure S3. Expression of GLI1 within E14.5 mouse
embryo. In situ hybridization of GLI1 (image from genepaint.org, EN1215)
showing active Hh signaling at E14.5 in liver but not heart. (JPG 216 kb)
Additional file 8: Table S5. PCR primers for amplification of mouse
genomic regions. Mouse genomic coordinates (mm9) for primer sequence
used to amplify candidate regions. (XLSX 10 kb)
Abbreviations
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